Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs United Microelectronics Corp (UMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs United Microelectronics Corp — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while United Microelectronics Corp trades at $20.43 (market cap $55.52B). The key difference: United Microelectronics Corp is the larger of the two by market cap, and United Microelectronics Corp pays the higher dividend (1.79%). Which is the better fit depends on your goals.
| GEHC | UMC | |
|---|---|---|
Market Cap | $31.07B | $55.52B |
Volume | 3,443,020 | 8,712,351 |
Sector | Health | Technology |
52-Week High | $88.16 | $28.02 |
52-Week Low | $59.48 | $7.02 |
Enterprise Value | $39.53B | $52.61B |
Dividend Yield | 0.23% | 1.79% |
Typical Hold Time | — | 42 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
UMC trades at $21.40, down 5.1% in the past 24 hours, with mixed technical signals showing a bearish moving average trend but oversold RSI conditions. Fundamentally, the company demonstrates strong profitability with 32.75% net income margin and has beaten earnings estimates for three consecutive quarters, though revenue growth remains modest at 2.3% year-over-year for 2025.
The stock presents a mixed outlook with strong earnings performance and attractive valuation metrics offset by slowing revenue growth and competitive pressures. Analyst sentiment leans cautious with a 'Hold' consensus, while technical indicators suggest potential near-term support around current levels given oversold conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About United Microelectronics Corp
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →
